Analystreport

Syros Pharmaceuticals Inc (NASDAQ: SYRS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com